- 75.0% Response Rate and Median PFS of 10.9 Months Observed in First-Line Recurrent or Metastatic Head and Neck Cancer(R/M HNSCC)
- Advancing Tosposertib Toward Next-Stage Development as a Potential Best-in-Class Treatment Option
SEONGNAM, South Korea, May 31, 2026 /PRNewswire/ -- TiumBio Co., Ltd. (KOSDAQ: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics, announced clinical data for Tosposertib (TU2218), an oral dual inhibitor targeting transforming growth factor-beta (TGF-β) and vascular endothelial growth factor (VEGF), in first-line (1L) recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) at American Society of Clinical Oncology (ASCO) 2026.
k5:G 4=2DDlQ!#}0x>365565pDD6E#676C6?46Q :5lQs:GpDD6E!=246w@=56C`QmkAmk2 9C67lQ9EEADi^^>>2]AC?6HDH:C6]4@>^>65:2^ahh`ded^E:F>3:@0=@8@09@C:K@?E2=0400f0{@8@0{@8@]9E>=Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmk^2mk^Amk^5:Gm
kAm%96 52E2 AC6D6?E65 5FC:?8 E96 A@DE6C D6DD:@? :?4=F565 E96 =2E6DE C6DF=ED 2?5 7@==@H\FA 52E2 7C@> E96 !92D6 a2 EC:2= 6G2=F2E:?8 E96 4@>3:?2E:@? @7 %@DA@D6CE:3 2?5 z6JECF52 W!6>3C@=:KF>23X kDA2? :5lQDA2?w89=EcdfhQm2D] x? 255:E:@?k^DA2?m E@ E96 fdT C6DA@?D6 C2E6 :? E96 7:CDE\=:?6 W`{X A2E:6?E 8C@FA W:?4=F5:?8 ` r# 2?5 g !#X[ H9:49 5C6H 2EE6?E:@? FA@? 23DEC24E C6=62D6 @? |2J aa[ E96 AC6D6?E2E:@? 2=D@ 5:D4=@D65 AC@8C6DD:@?\7C66 DFCG:G2= W>!u$X 2?5 @G6C2== DFCG:G2= W>~$X 52E2 7@C E96 7:CDE E:>6]k^Am
kAmp44@C5:?8 E@ E96 C6D62C49 A@DE6C AC6D6?E65 3J %:F>3:@ 2E p$r~ a_ae[ 2D @7 E96 52E2 4FE@77 52E6 @7 |2C49 b`[ a_ae[ E96 >65:2? AC@8C6DD:@?\7C66 DFCG:G2= W>!u$YX :? 2 E@E2= @7 `a 7:CDE\=:?6 W`{X A2E:6?ED H2D `_]h >@?E9D] (9:=6 4C@DD\EC:2= 4@>A2C:D@?D 2C6 :?96C6?E=J =:>:E65[ E9:D C6DF=E 4@>A2C6D 72G@C23=J H:E9 9:DE@C:42==J C6A@CE65 !u$ @FE4@>6D 7@C DE2?52C5\@7\42C6 A6>3C@=:KF>23 >@?@E96C2AJ 2?5 A6>3C@=:KF>23 A=FD 496>@E96C2AJ] x? 255:E:@?[ 2? gbT C6DA@?D6 C2E6 H2D @3D6CG65 :? E96 9:89 r!$ WU8Eja_X DF38C@FA W?leX[ H9:=6 2 efT C6DA@?D6 C2E6 H2D 2=D@ @3D6CG65 :? E96 =@H r!$ `–`h DF38C@FA W?leX[ 2 A2E:6?E A@AF=2E:@? E92E >2J 56C:G6 C6=2E:G6=J =:>:E65 36?67:E 7C@> :>>F?@\@?4@=@8J E96C2A:6D]k^Am
kAm%96 >65:2? @G6C2== DFCG:G2= W>~$YX 925 ?@E J6E 366? C624965 W}#X[ H:E9 2 DF3DE2?E:2= AC@A@CE:@? @7 A2E:6?ED C6>2:?:?8 2=:G6 2?5 4@?E:?F:?8 @? EC62E>6?E @C 7@==@H\FA 2E E96 E:>6 @7 2?2=JD:D]k^Am
k5:GmkE23=6 3@C56ClQ_Q 46==DA24:?8lQ_Q 46==A255:?8lQ`Q 4=2DDlQAC?344QmkECmkE5 4=2DDlQAC?ACa AC?A=a AC?D3E3` AC?C3C3` AC?D333` AC?D3=3`Q 4@=DA2?lQ`Q C@HDA2?lQ`QmkA 4=2DDlQAC?>=cQmkDA2? 4=2DDlQAC?6HD0DA2?QmWYX >!u$ W|65:2? !C@8C6DD:@?\uC66 $FCG:G2=Xi E96 >65:2? =6?8E9 @7 E:>6 5FC:?8 H9:49 d_T @7 A2E:6?ED 6?C@==65 :? E96 4=:?:42= EC:2= 6IA6C:6?465 ?6:E96C 5:D62D6 AC@8C6DD:@? ?@C 562E9]k3C ^mk3C ^mWYX >~$ W|65:2? ~G6C2== $FCG:G2=Xi E96 >65:2? =6?8E9 @7 E:>6 7C@> :?:E:2E:@? @7 EC62E>6?E :? E96 4=:?:42= EC:2= F?E:= 562E9 7C@> 2?J 42FD6[ C682C5=6DD @7 5:D62D6 AC@8C6DD:@?]k^DA2?mk^Amk^E5mk^ECmk^E23=6mk^5:Gm
kAm%96 52E2D6E :?4=F565 `c A2E:6?ED C646:G:?8 akDFAm?5k^DFAm\=:?6 @C =2E6C EC62E>6?E 27E6C C6=2AD6 7@==@H:?8 AC:@C DE2?52C5 E96C2AJ] x? E9:D DF38C@FA[ E96 4@>3:?2E:@? 249:6G65 2 C6DA@?D6 C2E6 @7 ca]hT W:?4=F5:?8 `r# 2?5 d !#X] %96 >!u$ H2D a]h >@?E9D[ H9:=6 >~$ 925 ?@E J6E 366? C624965 W}#X] qJ 4@>A2C:D@?[ 4FCC6?E=J 2G2:=23=6 DE2?52C5 EC62E>6?E @AE:@?D :? akDFAm?5k^DFAm\=:?6 @C =2E6C D6EE:?8D 7@C #^| w}$rr EJA:42==J D9@H C6DA@?D6 C2E6D @7 2AAC@I:>2E6=J `_T E@ `dT[ H:E9 >!u$ @7 a]` >@?E9D] %96D6 7:?5:?8D DF886DE E92E %@DA@D6CE:3 2?5 z6JECF52 4@>3:?2E:@? >2J @776C >62?:?87F= 4=:?:42= 25G2?E286 6G6? :? =2E6C\=:?6 A2E:6?ED H9@ 92G6 =:>:E65 EC62E>6?E @AE:@?D 27E6C 72:=FC6 @7 6I:DE:?8 E96C2A:6D]k^Am
kAmx? 255:E:@?[ E96 4@>3:?2E:@? H2D 86?6C2==J >2?28623=6[ 2?5 D276EJ 7:?5:?8D H6C6 86?6C2==J 4@?D:DE6?E H:E9 E96 <?@H? AC@7:=6D @7 E96 286?ED 2?5 E96 F?56C=J:?8 A2E:6?E A@AF=2E:@?] %96 :?4:56?46 @7 vC256 b @C 9:896C EC62E>6?E\C6=2E65 25G6CD6 6G6?ED W%#ptDX @3D6CG65 H:E9 E96 4@>3:?2E:@? @7 %@DA@D6CE:3 2?5 z6JECF52 H2D cg]bT] }@ vC256 d EC62E>6?E\C6=2E65 25G6CD6 6G6?ED =625:?8 E@ A2E:6?E 562E9 @C 42C5:@G2D4F=2C E@I:4:E:6D H6C6 C6A@CE65]k^Am
kAm!C@76DD@C wJ6 #JF? z:> @7 E96 s:G:D:@? @7 |65:42= ~?4@=@8J 2E *@?D6: &?:G6CD:EJ $6G6C2?46 w@DA:E2=[ @?6 @7 z@C62VD =625:?8 6IA6CED :? 9625 2?5 ?64< 42?46C EC62E>6?E 2?5 E96 7:CDE 2FE9@C H9@ A6CD@?2==J AC6D6?E65 E96 A@DE6C 2E p$r~[ 4@>>6?E65[ Q%96 :?E6C:> 52E2 AC6D6?E65 2E p$r~ a_ae C6AC6D6?ED 2 5:776C6?E:2E65 4=:?:42= @FE4@>6 E92E 9:89=:89ED E96 A@E6?E:2= E96C2A6FE:4 36?67:E @7 %@DA@D6CE:3 :? C64FCC6?E @C >6E2DE2E:4 9625 2?5 ?64< 42?46C] x? E9:D 5:D62D6 D6EE:?8[ H96C6 EC62E>6?E C6>2:?D 492==6?8:?8 2?5 A2E:6?E AC@8?@D:D :D @7E6? A@@C[ H6 36=:6G6 %@DA@D6CE:3 92D D:8?:7:42?E A@E6?E:2= E@ 6>6C86 2D 2 ?6H EC62E>6?E @AE:@? 42A23=6 @7 255C6DD:?8 E96 =:>:E2E:@?D @7 6I:DE:?8 E96C2A:6D]QÂ k^Am
kAmkDA2? :5lQDA2?w89=Eh65hQmwF?\E26< z:>[ rt~ @7 %:F>3:@[ DE2E65[ Q(6 36=:6G6 E96D6 :?E6C:> 52E2 AC6D6?E65 2E p$r~ a_ae 56>@?DEC2E65 2 4@>A6==:?8 4=:?:42= AC@7:=6 4@>A2C65 H:E9 @FE4@>6D 9:DE@C:42==J @3D6CG65 H:E9 4FCC6?E DE2?52C5 @7 42C6] q2D65 @? E96D6 52E2[ H6 A=2? E@ 6G2=F2E6 A@E6?E:2= C68F=2E@CJ A2E9H2JD[ :?4=F5:?8 E96 A@DD:3:=:EJ @7 D66<:?8 qC62<E9C@F89 %96C2AJ s6D:8?2E:@?[ 2D H6 4@?E:?F6 E@ 25G2?46 %@DA@D6CE:3 E@H2C5 :ED A@E6?E:2= E@ 364@>6 2 ?6H DE2?52C5 @7 42C6 :? #^| w}$rr]Qk^DA2?mk^Am
kAmkDEC@?8mp3@FE %@DA@D6CE:3 W%&aa`gXk^Am
kAmk^DEC@?8m%@DA@D6CE:3 W%&aa`gX :D 2 9:89=J A@E6?E[ @C2= 5F2= :?9:3:E@C 56D:8?65 E@ 3=@4< E96 D:8?2=:?8 A2E9H2JD @7 EC2?D7@C>:?8 8C@HE9 724E@C\36E2 W%vu\βX 2?5 G2D4F=2C 6?5@E96=:2= 8C@HE9 724E@C W'tvuX[ EH@ 4C:E:42= >65:2E@CD @7 EF>@C 8C@HE9 2?5 >6E2DE2D:D] %9:D ?@G6= 5CF8 42?5:52E6 H2D 5:D4@G6C65 2?5 56G6=@A65 3J %:F>3:@ E@ 6?92?46 E96 E96C2A6FE:4 677:424J @7 :>>F?6\@?4@=@8J 286?ED DF49 2D z6JECF52]k^Am
kAmkDEC@?8mp3@FE %:F>3:@ r@][ {E5]k^Am
kAmk^DEC@?8m%:F>3:@ :D 565:42E65 E@ E96 5:D4@G6CJ 2?5 56G6=@A>6?E @7 :??@G2E:G6 E96C2A:6D E92E 2==6G:2E6 E96 3FC56? @7 D6C:@FD 2?5 563:=:E2E:?8 5:D62D6] %:F>3:@VD >:DD:@? :D E@ 6IA2?5 9@A6 2?5 :>AC@G6 E96 BF2=:EJ @7 =:76 7@C A6@A=6 E9C@F89 D4:6?46] u@C 7FCE96C :?7@C>2E:@?[ G:D:E @FC H63D:E6 2E k2 9C67lQ9EEAi^^HHH]E:F>3:@]4@>^6?Q C6=lQ?@7@==@HQmHHH]E:F>3:@]4@>^6?k^2m 2?5 4@??64E H:E9 FD @? {:?<65x?]k^Am
kAmr@?E24EDik^Am
kAms@?8\9@ z2?8[ w625 @7 r@CA@C2E6 r@>>F?:42E:@?D U2>Aj x?G6DE@C #6=2E:@?Dk^Am
kAmk2 9C67lQ>2:=E@i5@?89@<2?8oE:F>3:@]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm5@?89@<2?8oE:F>3:@]4@>k^2mk^Am
kAms2\J6 $@?8[ |2?286C[ r@CA@C2E6 r@>>F?:42E:@?D U2>Aj x?G6DE@C #6=2E:@?Dk^Am
kAmk2 9C67lQ>2:=E@i52J6D@?8oE:F>3:@]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm52J6D@?8oE:F>3:@]4@>k^2mk^Am
kAmwJF?\<J@F?8 z:>[ [ |2?286C[ r@CA@C2E6 r@>>F?:42E:@?D U2>Aj x?G6DE@C #6=2E:@?Dk^Am
kAmk2 9C67lQ>2:=E@i9JF?<J@F?8<:>oE:F>3:@]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm9JF?<J@F?8<:>oE:F>3:@]4@>k^2mk^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lr}fa_`cU2>AjD5la_ae\_d\b`Q ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^E:F>3:@\E@\AC6D6?E\A92D6\a2\:?E6C:>\52E2\9:89=:89E:?8\5:776C6?E:2E65\4=:?:42=\AC@7:=6\7@C\E@DA@D6CE:3EFaa`g\A=FD\A6>3C@=:KF>23\:?\7:CDE\=:?6\C>\9?D44\2E\2D4@\a_ae\b_afgeddg]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^E:F>3:@\E@\AC6D6?E\A92D6\a2\:?E6C:>\52E2\9:89=:89E:?8\5:776C6?E:2E65\4=:?:42=\AC@7:=6\7@C\E@DA@D6CE:3EFaa`g\A=FD\A6>3C@=:KF>23\:?\7:CDE\=:?6\C>\9?D44\2E\2D4@\a_ae\b_afgeddg]9E>=k^2mk^Am
kAm$~&#rt %:F>q:@k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}fa_`cU2>Aj%C2?D>:DD:@?0x5la_ae_db``hb_!#0}t($0&$!#00000r}fa_`cU2>Ajs2E6x5la_ae_db`Q DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
